Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2009
02/19/2009DE102008031478A1 Detektion von Wasser in Kraftstoff mit Hilfe von Arbeitszyklusberechnung Detection of water in fuel using duty cycle calculation
02/19/2009DE102007038777A1 Zellkulturmesssystem und Verfahren für vergleichende Untersuchungen an Zellkulturen Cell culture measuring system and method for comparative studies on cell cultures
02/19/2009DE102007038730A1 Nachweis des menschlichen Vascular Endothelial Growth Factor Detection of the human Vascular Endothelial Growth Factor
02/19/2009DE102007037008A1 Diagnosesubstanz zur Anwendung in einem Verfahren zur Bestimmung der Aggressivität eines Prostatatumors und Diagnoseverfahren Diagnostic substances for use in a method for determining the aggressiveness of a prostate tumor and diagnostic methods
02/19/2009DE102007036437A1 Method for producing application data for low stress annealing of attached series components made of metal, particularly in motor vehicle, involves connecting multiple individual units having solid or tubing material by arc welding
02/19/2009DE102005050167B4 Konzentrationsverfahren, Konzentrationsvorrichtung und Reaktionsverfahren Concentration method, concentrator and response procedures
02/19/2009CA2733672A1 Tumor cell-derived microvesicles
02/19/2009CA2700923A1 Novel targets and compounds for therapeutic intervention of hiv infection
02/19/2009CA2696843A1 Method, system and software arrangement for comparative analysis and phylogeny with whole-genome optical maps
02/19/2009CA2696364A1 Article, device, and method
02/19/2009CA2696360A1 Monoclonal antibody 175 targeting the egf receptor and derivatives and uses thereof
02/19/2009CA2696047A1 A method for identifying, expanding, and removing adult stem cells and cancer stem cells
02/19/2009CA2695994A1 Use of c3 to c14 aliphatic aldehydes, ketones and primary and secondary c3 to c7 aliphatic alcohols to inhibit sprouting of potato tubers
02/19/2009CA2694863A1 Agents and methods for modulating macrophage inhibitory cytokine (mic-1) activity
02/19/2009CA2686465A1 Antibodies and improved test sample handling methods for use in assays for myeloperoxidase
02/19/2009CA2684873A1 Anti-bacterial drug targeting of genome maintenance interfaces
02/18/2009EP2026074A2 Centrifugal force-based microfluidic device for nucleic acid detection and microfluidic system including the same
02/18/2009EP2026073A1 Diagnostics and therapeutics for macular degeneration-related disorders
02/18/2009EP2026072A1 Cromatographic assay system
02/18/2009EP2026071A2 Identification of cancer protein biomarkers using proteomic techniques
02/18/2009EP2026070A1 Methods of diagnosing cervical cancer
02/18/2009EP2026069A1 Container for determining particle agglutination
02/18/2009EP2026068A1 Method for producing purified and/or concentrated analytes, use and kit
02/18/2009EP2026067A1 Method for detection of disease having insulin-resistant condition
02/18/2009EP2026064A2 Flue Gas Analyser comprising an electrochemical oxygen sensor
02/18/2009EP2026060A1 Optical detection apparatus based on phase-shift interferometry
02/18/2009EP2025762A2 Heteroduplex tracking assay
02/18/2009EP2025754A2 Moraxella (Branhamella) catarrhalis antigens
02/18/2009EP2025753A2 Phagemid for screening antibodies
02/18/2009EP2025750A1 Novel targets and compounds for therapeutic intervention of HIV infection
02/18/2009EP2025749A1 Humanized anti-human osteopontin antibody
02/18/2009EP2025744A1 Method and system for counting the cells in a biological culture medium on line and in situ
02/18/2009EP2025686A2 Alpha anticholine kinase monoclonal antibodies and their use in analytical techniques for the diagnosis of cancer and the preparation of medicinal products
02/18/2009EP2024893A2 A laser illumination system in fluorescent microscopy
02/18/2009EP2024888A1 Information management techniques for metabolism-related data
02/18/2009EP2024757A1 System and methods for actuation on magnetoresistive sensors
02/18/2009EP2024748A2 Monoclonal anti-annexin a3 antibodies for the detection of prostate carcinoma
02/18/2009EP2024747A1 Use of protein satb2 as a marker for colorectal cancer
02/18/2009EP2024746A2 Use of gpr101 receptor in methods to identify modulators of hypothalamic proopiomelanocortin (pomc)-derived biologically active peptide secretion useful in the treatment of pomc-derived biologically active peptide-related disorders
02/18/2009EP2024745A2 Assays for diagnosing and evaluating treatment options for fabry disease
02/18/2009EP2024744A1 Microtiter plate and use thereof
02/18/2009EP2024743A1 A method for measuring breath temperature in breath alcohol testing
02/18/2009EP2024742A2 System and method for preparing samples
02/18/2009EP2024740A1 Method for detection and classification of imperfections in components by means of ultrasound
02/18/2009EP2024727A1 Method for determining the viability of cells in cell cultures
02/18/2009EP2024520A1 Method of protein extraction from cells
02/18/2009EP2024512A2 Methods for the diagnosis of fetal abnormalities
02/18/2009EP2024511A1 Cholesterol-regulating complex of sirt1 and lxr and methods of use
02/18/2009EP2024509A1 Detection method
02/18/2009EP2024500A1 Gene family (lbfl313) associated with pancreatic cancer
02/18/2009EP2024497A2 Liga and ligb proteins (leptospiral ig-like (lig) domains) for vaccination and diagnosis
02/18/2009EP2024488A2 Metal-enhanced chemiluminescence (mec)
02/18/2009EP2024393A2 Neutralizing antibodies to influenza viruses
02/18/2009EP2024386A2 Use of proteins and peptides of the tgf-beta superfamily for purification and therapeutic methods
02/18/2009EP2024362A1 Iap bir domain binding compounds
02/18/2009EP2023897A1 Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
02/18/2009EP2023874A2 Methods for identifying agents and their use for the prevention of restenosis
02/18/2009EP2023802A2 Test sensor with under-fill protection
02/18/2009EP1952149A4 High throughput screening assay for the trpm5 ion channel
02/18/2009EP1952138A4 Method for detecting an inflammatory disease or cancer
02/18/2009EP1913391A4 QUANTITATIVE ASSAYS FOR PDGFR-beta IN BODY FLUIDS
02/18/2009EP1909852A4 Amyloid beta protein channel structure and uses thereof indentifying potential drug molecules for neurodegenerative diseases
02/18/2009EP1899732A4 Shape tunable plasmonic nanoparticles
02/18/2009EP1893997A4 Quantitative assays for ras p21 in body fluids
02/18/2009EP1812792A4 Analysis for glucose products using pyridinylboronic acid
02/18/2009EP1740223A4 Method for characterizing the oxidative stress protective capacity of an antioxidative substance
02/18/2009EP1695086B1 Methods for detecting bacterial pathogens
02/18/2009EP1679372B1 Novel plexin polypeptide, dna encoding the same and use thereof
02/18/2009EP1660634A4 P16 mediated regulation of nmda receptors
02/18/2009EP1618388B1 Proteomic analysis of biological fluids
02/18/2009EP1587409A4 Diagnosis and monitoring of inflammation, ischemia and appendicitis
02/18/2009EP1576368B1 Methods and compositions for enhancing fibrocyte formation
02/18/2009EP1576180B1 Ampk pathway components
02/18/2009EP1573336B1 Prp detection method using a group ii aminoglycoside antibiotic
02/18/2009EP1555325B1 Novel fructosyl peptide oxidase and utilization thereof
02/18/2009EP1552303B1 Biosensor for detecting glucose
02/18/2009EP1507145B1 Biomolecular substrate and test device
02/18/2009EP1489968B1 Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples
02/18/2009EP1456661B1 Binding assay device with non-absorbent carrier material
02/18/2009EP1452865B1 Composition for blood serum or plasma separation and vessel for blood examination containing the same
02/18/2009EP1442291B1 Biological marker for stress states
02/18/2009EP1416055B1 Method of efficiently detecting double-stranded nucleic acid
02/18/2009EP1393136B1 Method for monitoring and detecting sensor failure in oil and gas production system
02/18/2009EP1346034B1 VON WILLEBRAND FACTOR (vWF) CLEAVING PROTEASE POLYPEPTIDE, NUCLEIC ACID ENCODING THE POLYPEPTIDE AND USE OF POLYPEPTIDE
02/18/2009EP1238110B1 Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated rna decay
02/18/2009EP1181554B1 Method for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses
02/18/2009EP1135467B1 Psca: prostate stem cell antigen and uses thereof
02/18/2009EP1104405B1 Near infrared chemiluminescent acridinium compounds and uses thereof
02/18/2009EP1090293B1 Decoding of array sensors with microspheres
02/18/2009EP1071955B2 Improved immunodiagnostic assays using reducing agents
02/18/2009EP0965041B1 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease
02/18/2009EP0941337B1 Synthesis and purification of hepatitis c virus-like particles
02/18/2009CN201196651Y Gold mark detection test paper for double-tumor token
02/18/2009CN201196650Y Portable fast joint inspection device for multiple tumor tokens
02/18/2009CN201196649Y Portable fast joint inspection device for foetus teratogenic disease
02/18/2009CN201196648Y Test device for glucose in urine of diabetes patient
02/18/2009CN201196647Y Pathology material drawing plate
02/18/2009CN201196646Y Environment simulator for asphalt mixture hydrosphere stability test
02/18/2009CN201196645Y Multifunctional track test apparatus
02/18/2009CN201196644Y Asphalt mixture low-temperature fatigue experiment apparatus